ME Staff
-
0

Analyst Ratings For NASDAQ:CELG – Celgene (NASDAQ:CELG)

.

Some recent analyst ratings include

  • 5/7/2018-Royal Bank of Canada was Downgraded by analysts at Royal Bank of Canada from a “Top Pick ➝ Outperform” rating to a “” rating. They now have a $120.00 ➝ $118.00 price target on the stock.
  • 4/30/2018-Evercore ISI Reiterated Rating of Buy.
  • 4/13/2018-Morgan Stanley Reiterated Rating of Equal ➝ Equal Weight.

Recent Insider Trading Activity For NASDAQ:CELG – Celgene (NASDAQ:CELG)
NASDAQ:CELG – Celgene (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 81.13%.

  • On 3/12/2018 James J Loughlin, Director, sold 9,250 with an average share price of $92.01 per share and the total transaction amounting to $851,092.50.
  • On 2/23/2018 Ernest Mario, Director, sold 13,370 with an average share price of $94.49 per share and the total transaction amounting to $1,263,331.30.
  • On 2/20/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $94.83 per share and the total transaction amounting to $877,177.50.
  • On 2/15/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $95.99 per share and the total transaction amounting to $887,907.50.
  • On 2/8/2018 Mark J Alles, Insider, bought 3,260 with an average share price of $91.90 per share and the total transaction amounting to $299,594.00.
  • On 9/25/2017 Terrie Curran, Insider, sold 1,727 with an average share price of $143.89 per share and the total transaction amounting to $248,498.03.
  • On 9/12/2017 Gilla Kaplan, Director, sold 9,250 with an average share price of $141.56 per share and the total transaction amounting to $1,309,430.00.

Recent Trading Activity for NASDAQ:CELG – Celgene (NASDAQ:CELG)
Shares of NASDAQ:CELG – Celgene closed the previous trading session at 84.60 down -2.29 2.64% with 86.5 shares trading hands.